154 related articles for article (PubMed ID: 38803574)
1. Antibiofilm activity of carotenoid crocetin against Staphylococcal strains.
Paramanya S; Lee JH; Lee J
Front Cell Infect Microbiol; 2024; 14():1404960. PubMed ID: 38803574
[No Abstract] [Full Text] [Related]
2. Melittin and its potential in the destruction and inhibition of the biofilm formation by Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa isolated from bovine milk.
Picoli T; Peter CM; Zani JL; Waller SB; Lopes MG; Boesche KN; Vargas GDÁ; Hübner SO; Fischer G
Microb Pathog; 2017 Nov; 112():57-62. PubMed ID: 28943153
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains.
Liu H; Zhao Y; Zhao D; Gong T; Wu Y; Han H; Xu T; Peschel A; Han S; Qu D
Emerg Microbes Infect; 2015 Jan; 4(1):e1. PubMed ID: 26038759
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial Properties and Efficacy of LL-37 Fragment GF-17D3 and Scolopendin A2 Peptides Against Resistant Clinical Strains of Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii In Vitro and In Vivo Model Studies.
Farzi N; Oloomi M; Bahramali G; Siadat SD; Bouzari S
Probiotics Antimicrob Proteins; 2024 Jun; 16(3):796-814. PubMed ID: 37148452
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial and antibiofilm activities of prenylated flavanones from Macaranga tanarius.
Lee JH; Kim YG; Khadke SK; Yamano A; Woo JT; Lee J
Phytomedicine; 2019 Oct; 63():153033. PubMed ID: 31352284
[TBL] [Abstract][Full Text] [Related]
6. Small Molecules Produced by Commensal Staphylococcus epidermidis Disrupt Formation of Biofilms by Staphylococcus aureus.
Glatthardt T; Campos JCM; Chamon RC; de Sá Coimbra TF; Rocha GA; de Melo MAF; Parente TE; Lobo LA; Antunes LCM; Dos Santos KRN; Ferreira RBR
Appl Environ Microbiol; 2020 Feb; 86(5):. PubMed ID: 31862721
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of gallium maltolate against Staphylococci in logarithmic, stationary, and biofilm growth phases: comparison of conventional and calorimetric susceptibility testing methods.
Baldoni D; Steinhuber A; Zimmerli W; Trampuz A
Antimicrob Agents Chemother; 2010 Jan; 54(1):157-63. PubMed ID: 19805560
[TBL] [Abstract][Full Text] [Related]
8. Combination antimicrobial therapy: in vitro synergistic effect of anti-staphylococcal drug oxacillin with antimicrobial peptide nisin against Staphylococcus epidermidis clinical isolates and Staphylococcus aureus biofilms.
Sharafi T; Ghaemi EA; Rafiee M; Ardebili A
Ann Clin Microbiol Antimicrob; 2024 Jan; 23(1):7. PubMed ID: 38245727
[TBL] [Abstract][Full Text] [Related]
9. Discovery of quinolinequinones with N-phenylpiperazine by conversion of hydroxyquinoline as a new class of antimicrobial agents targeting resistant pathogenic microorganisms.
Yıldız M; Bayrak N; Yıldırım H; Çakmak SM; Yılmaz FN; Mataracı-Kara E; Shilkar D; Jayaprakash V; TuYuN AF
Bioorg Chem; 2022 Nov; 128():106045. PubMed ID: 35921788
[TBL] [Abstract][Full Text] [Related]
10. Aryl rhodanines specifically inhibit staphylococcal and enterococcal biofilm formation.
Opperman TJ; Kwasny SM; Williams JD; Khan AR; Peet NP; Moir DT; Bowlin TL
Antimicrob Agents Chemother; 2009 Oct; 53(10):4357-67. PubMed ID: 19651903
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial evaluation of selected naturally occurring oxyprenylated secondary metabolites.
Di Giulio M; Genovese S; Fiorito S; Epifano F; Nostro A; Cellini L
Nat Prod Res; 2016 Aug; 30(16):1870-4. PubMed ID: 27498831
[TBL] [Abstract][Full Text] [Related]
12. [Advances in the study of synergistic effect of anti-biofilm agents].
Wang CZ; Cheng HJ
Yao Xue Xue Bao; 2012 Mar; 47(3):339-45. PubMed ID: 22645757
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human DNase I decreases biofilm and increases antimicrobial susceptibility in staphylococci.
Kaplan JB; LoVetri K; Cardona ST; Madhyastha S; Sadovskaya I; Jabbouri S; Izano EA
J Antibiot (Tokyo); 2012 Feb; 65(2):73-7. PubMed ID: 22167157
[TBL] [Abstract][Full Text] [Related]
14. Short chain fatty acids produced by Cutibacterium acnes inhibit biofilm formation by Staphylococcus epidermidis.
Nakamura K; O'Neill AM; Williams MR; Cau L; Nakatsuji T; Horswill AR; Gallo RL
Sci Rep; 2020 Dec; 10(1):21237. PubMed ID: 33277548
[TBL] [Abstract][Full Text] [Related]
15. Oral administration of the broad-spectrum antibiofilm compound toremifene inhibits Candida albicans and Staphylococcus aureus biofilm formation in vivo.
De Cremer K; Delattin N; De Brucker K; Peeters A; Kucharíková S; Gerits E; Verstraeten N; Michiels J; Van Dijck P; Cammue BP; Thevissen K
Antimicrob Agents Chemother; 2014 Dec; 58(12):7606-10. PubMed ID: 25288093
[TBL] [Abstract][Full Text] [Related]
16.
Delpech G; Ceci M; Lissarrague S; García Allende L; Baldaccini B; Sparo M
Biofouling; 2020 Mar; 36(3):266-275. PubMed ID: 32338055
[No Abstract] [Full Text] [Related]
17. The Anticancer Agent 3,3'-Diindolylmethane Inhibits Multispecies Biofilm Formation by Acne-Causing Bacteria and Candida albicans.
Kim YG; Lee JH; Park S; Lee J
Microbiol Spectr; 2022 Feb; 10(1):e0205621. PubMed ID: 35107361
[TBL] [Abstract][Full Text] [Related]
18. Effect of Antimicrobial and Physical Treatments on Growth of Multispecies Staphylococcal Biofilms.
Stewart EJ; Payne DE; Ma TM; VanEpps JS; Boles BR; Younger JG; Solomon MJ
Appl Environ Microbiol; 2017 Jun; 83(12):. PubMed ID: 28411222
[TBL] [Abstract][Full Text] [Related]
19. Effect of ZnO nanoparticles on methicillin, vancomycin, linezolid resistance and biofilm formation in Staphylococcus aureus isolates.
Abdelraheem WM; Khairy RMM; Zaki AI; Zaki SH
Ann Clin Microbiol Antimicrob; 2021 Aug; 20(1):54. PubMed ID: 34419054
[TBL] [Abstract][Full Text] [Related]
20. N
Reis SVD; Ribeiro NS; Rocha DA; Fortes IS; Trentin DDS; Andrade SF; Macedo AJ
Chem Biol Drug Des; 2020 Dec; 96(6):1372-1379. PubMed ID: 32542979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
